Extract from the Register of European Patents

EP About this file: EP2966084

EP2966084 - MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.03.2019
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  23.03.2018
FormerGrant of patent is intended
Status updated on  10.09.2017
FormerExamination is in progress
Status updated on  27.01.2017
Most recent event   Tooltip03.07.2020Lapse of the patent in a contracting state
New state(s): CY, MK
published on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Taiga Biotechnologies, Inc.
12635 East Montview Boulevard
Aurora, CO 80045-7336 / US
[2016/02]
Inventor(s)01 / REFAELI, Yosef
843 Garfield Street
Denver, CO 80206 / US
02 / TURNER, Brian Curtis
655 S. Glencoe Street
Denver, CO 80246 / US
 [2016/02]
Representative(s)Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
[2018/17]
Former [2016/02]Atkinson, Jennifer
Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham B16 8QQ / GB
Application number, filing date15175802.628.08.2009
[2016/02]
Priority number, dateUS20080092708P28.08.2008         Original published format: US 92708 P
[2016/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2966084
Date:13.01.2016
Language:EN
[2016/02]
Type: B1 Patent specification 
No.:EP2966084
Date:25.04.2018
Language:EN
[2018/17]
Search report(s)(Supplementary) European search report - dispatched on:EP14.12.2015
ClassificationIPC:C07K14/82, C07K19/00, A61K38/16
[2016/02]
CPC:
A61P1/16 (EP,IL); C07K14/47 (IL,US); A61K39/39 (IL,US);
A61K38/00 (EP,IL,US); A61P19/02 (EP,IL); A61P29/00 (EP,IL);
A61P31/00 (EP,IL); A61P31/04 (EP,IL); A61P31/06 (EP,IL);
A61P31/12 (EP,IL); A61P31/14 (EP,IL); A61P31/16 (EP,IL);
A61P31/20 (EP,IL); A61P33/00 (EP,IL); A61P37/02 (EP,IL);
A61P37/04 (EP,IL); A61P43/00 (EP,IL); C07K14/001 (IL,US);
C07K14/82 (EP,IL,US); C07K2319/02 (IL,US); C07K2319/21 (IL,US);
Y02A50/30 (EP,IL,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/32]
Former [2016/02]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:MYC-MODULATOREN, VERFAHREN ZUR VERWENDUNG DAVON UND VERFAHREN ZUR IDENTIFIKATION VON MITTELN ZUR MYC-MODULIERUNG[2016/02]
English:MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC[2016/02]
French:MODULATEURS DE MYC, LEURS PROCÉDÉS D'UTILISATION ET DES PROCÉDÉS D'IDENTIFICATION D'AGENTS MODULANT UN MYC[2016/02]
Examination procedure30.06.2016Amendment by applicant (claims and/or description)
30.06.2016Examination requested  [2016/32]
31.01.2017Despatch of a communication from the examining division (Time limit: M01)
24.02.2017Reply to a communication from the examining division
11.09.2017Communication of intention to grant the patent
10.01.2018Receipt of the translation of the claim(s)
23.02.2018Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
13.03.2018Fee for grant paid
13.03.2018Fee for publishing/printing paid
Parent application(s)   TooltipEP09810692.5  / EP2318435
Divisional application(s)EP18154875.1  / EP3339321
EP21170329.3
Opposition(s)28.01.2019No opposition filed within time limit [2019/14]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
13.03.2018Request for further processing filed
13.03.2018Full payment received (date of receipt of payment)
Request granted
21.03.2018Decision despatched
Fees paidRenewal fee
08.07.2015Renewal fee patent year 03
08.07.2015Renewal fee patent year 04
08.07.2015Renewal fee patent year 05
08.07.2015Renewal fee patent year 06
08.07.2015Renewal fee patent year 07
22.08.2016Renewal fee patent year 08
22.08.2017Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.08.2009
AT25.04.2018
CY25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
MK25.04.2018
PL25.04.2018
RO25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
MT28.08.2018
[2020/31]
Former [2020/30]HU28.08.2009
AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
MT28.08.2018
Former [2020/16]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
TR25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
MT28.08.2018
Former [2020/08]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
MT28.08.2018
Former [2019/26]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SI25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
Former [2019/21]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
LU28.08.2018
Former [2019/15]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
MC25.04.2018
PL25.04.2018
RO25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/11]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RO25.04.2018
SK25.04.2018
SM25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/10]AT25.04.2018
CZ25.04.2018
EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
RO25.04.2018
SK25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/09]EE25.04.2018
HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
Former [2019/03]HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
BG25.07.2018
GR26.07.2018
PT27.08.2018
Former [2018/52]HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
BG25.07.2018
GR26.07.2018
Former [2018/51]HR25.04.2018
LT25.04.2018
LV25.04.2018
PL25.04.2018
BG25.07.2018
Former [2018/50]HR25.04.2018
LT25.04.2018
PL25.04.2018
BG25.07.2018
Former [2018/47]LT25.04.2018
Documents cited:Search[E] WO2009139930  (TAIGA BIOTECHNOLOGIES INC et al.)
 [Y] WO2007047583  (NAT JEWISH MED & RES CENTER et al.)
 [Y]   REFAELI Y ET AL: "The protooncogene MYC can break B cell tolerance", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, WASHINGTON, DC; US, vol. 102, no. 11, 1 March 2005 (2005-03-01), pages 4097 - 4102, XP008116683, ISSN: 0027-8424, DOI: 10.1073/PNAS.0409832102

DOI:   http://dx.doi.org/10.1073/pnas.0409832102
by applicantUS4816567
 US2008070256
   MORRISON ET AL., PROC. NATL ACAD. SCI., vol. 81, 1984, pages 6851 - 6855
   JONES ET AL., NATURE, vol. 321, 1986, pages 522 - 525
   REICHMANN ET AL., NATURE, vol. 332, 1988, pages 323 - 329
   PRESTA, CURR. OP. STRUCT. BIOL., vol. 2, 1992, pages 593 - 596
   BATZER ET AL., NUCLEIC ACID RES., vol. 19, 1991, pages 5081
   OHTSUKA ET AL., J. BIOL. CHEM., vol. 260, 1985, pages 2605 - 2608
   ROSSOLINI ET AL., MOL. CELL. PROBES, vol. 8, 1994, pages 91 - 98
   KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA, 1990, pages 2264 - 2268
   KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. 5 USA, vol. 90, 1993, pages 5873 - 5877
   ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
   ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402
   HENIKOFF ET AL., PROC. NATL ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919
   KOHLER ET AL., NATURE, vol. 256, 1975, pages 495
   GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS
   WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
   HUSE ET AL., SCIENCE, vol. 246, 1989, pages 1275 - 1281
   MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 554
   CLACKSON ET AL., NATURE, vol. 352, 1991, pages 624 - 628
   MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597
   SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manua, second edition", 1989
   SAMBROOK AND RUSSEL,: "Molecular Cloning: A Laboratory Manual, third edition", 2001
   F. M. AUSUBEL ET AL.,: "Current Protocols in Molecular Biology", 1987
   "Current Protocols in Nucleic Acid Chemistry", 2000, JOHN WILEY & SONS, INC.
   "Remington: The Science and Practice of Pharmacy Nineteenth Ed", 1995, MACK PUBLISHING COMPANY
   HOOVER, JOHN E.: "Remington's Pharmaceutical Sciences", 1975, MACK PUBLISHING CO.
   LIBERMAN, H.A. AND LACHMAN, L.,: "Pharmaceutical Dosage Forms", 1980, MARCEL DECKER
   "Pharmaceutical Dosage Forms and Drug Delivery Systems, Seventh Ed.", 1999, LIPPINCOTT WILLIAMS & WILKINS
   GENNARO: "Remington's Pharmaceutical Sciences, 20th Edition", 2000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.